215 related articles for article (PubMed ID: 24248693)
1. Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma.
Chirieac LR; Barletta JA; Yeap BY; Richards WG; Tilleman T; Bueno R; Baldini EH; Godleski J; Sugarbaker DJ
J Clin Oncol; 2013 Dec; 31(36):4544-9. PubMed ID: 24248693
[TBL] [Abstract][Full Text] [Related]
2. Malignant (Diffuse) Mesothelioma in Patients With Hematologic Malignancies: A Clinicopathologic Study of 45 Cases.
Li X; Brownlee NA; Sporn TA; Mahar A; Roggli VL
Arch Pathol Lab Med; 2015 Sep; 139(9):1129-36. PubMed ID: 25844559
[TBL] [Abstract][Full Text] [Related]
3. [Malignant pleural mesothelioma after radiation treatment for Hodgkin lymphoma].
Vandenbos F; Figueredo M; Dumon-Gubeno MC; Nicolle I; Tarhini A; Butori C; Mouroux J
Rev Pneumol Clin; 2013 Oct; 69(5):291-3. PubMed ID: 23796498
[TBL] [Abstract][Full Text] [Related]
4. Non-Hodgkin Lymphoma and Pleural Mesothelioma in a Person Exposed to Asbestos.
Bianchi C; Bianchi T
Turk Patoloji Derg; 2018; 34(2):190-193. PubMed ID: 28272659
[TBL] [Abstract][Full Text] [Related]
5. Stratification of malignant pleural mesothelioma prognosis using recursive partitioning analysis.
Suzuki H; Asami K; Hirashima T; Okamoto N; Yamadori T; Tamiya M; Morishita N; Shiroyama T; Takeoka S; Osa A; Azuma Y; Okishio K; Kawaguchi T; Atagi S; Kawase I
Lung; 2014 Feb; 192(1):191-5. PubMed ID: 24141556
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and genetic characteristics of young patients with pleural diffuse malignant mesothelioma.
Vivero M; Bueno R; Chirieac LR
Mod Pathol; 2018 Jan; 31(1):122-131. PubMed ID: 28884745
[TBL] [Abstract][Full Text] [Related]
7. Almost half of women with malignant mesothelioma were exposed to asbestos at home through their husbands or sons.
Langhoff MD; Kragh-Thomsen MB; Stanislaus S; Weinreich UM
Dan Med J; 2014 Sep; 61(9):A4902. PubMed ID: 25186542
[TBL] [Abstract][Full Text] [Related]
8. Malignant Diffuse Mesothelioma in Women: A Study of 354 Cases.
Pavlisko EN; Liu B; Green C; Sporn TA; Roggli VL
Am J Surg Pathol; 2020 Mar; 44(3):293-304. PubMed ID: 31876584
[TBL] [Abstract][Full Text] [Related]
9. Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals.
Attanoos RL; Thomas DH; Gibbs AR
Histopathology; 2003 Oct; 43(4):387-92. PubMed ID: 14511258
[TBL] [Abstract][Full Text] [Related]
10. The Association between Malignant Pleural Mesothelioma and Thoracic Radiation Therapy for Hodgkin's Lymphoma: The First Case Report in Japan.
Nakashima K; Demura Y; Oi M; Tabata M; Tada T; Shiozaki K; Akai M; Ishizuka T
Intern Med; 2021 Mar; 60(5):771-775. PubMed ID: 33055477
[TBL] [Abstract][Full Text] [Related]
11. Malignant Mesothelioma and Its Non-Asbestos Causes.
Attanoos RL; Churg A; Galateau-Salle F; Gibbs AR; Roggli VL
Arch Pathol Lab Med; 2018 Jun; 142(6):753-760. PubMed ID: 29480760
[TBL] [Abstract][Full Text] [Related]
12. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
[TBL] [Abstract][Full Text] [Related]
13. Asbestos-related lung cancer and malignant mesothelioma of the pleura: selected current issues.
Markowitz S
Semin Respir Crit Care Med; 2015 Jun; 36(3):334-46. PubMed ID: 26024342
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors influencing survival in 35 patients with malignant peritoneal mesothelioma.
Kaya H; Sezgı C; Tanrıkulu AC; Taylan M; Abakay O; Sen HS; Abakay A; Kucukoner M; Kapan M
Neoplasma; 2014; 61(4):433-8. PubMed ID: 24645844
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma.
Berardi R; Fiordoliva I; De Lisa M; Ballatore Z; Caramanti M; Morgese F; Savini A; Rinaldi S; Torniai M; Tiberi M; Ferrini C; Onofri A; Cascinu S
Tumori; 2016; 102(2):190-5. PubMed ID: 26893272
[TBL] [Abstract][Full Text] [Related]
16. Myxoid variant epithelioid pleural mesothelioma defines a favourable prognosis group: an analysis of 191 patients with pleural malignant mesothelioma.
Alchami FS; Attanoos RL; Bamber AR
J Clin Pathol; 2017 Feb; 70(2):179-182. PubMed ID: 27798081
[TBL] [Abstract][Full Text] [Related]
17. Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival.
Verma V; Ahern CA; Berlind CG; Lindsay WD; Shabason J; Sharma S; Culligan MJ; Grover S; Friedberg JS; Simone CB
Clin Lung Cancer; 2018 Nov; 19(6):e901-e912. PubMed ID: 30224273
[TBL] [Abstract][Full Text] [Related]
18. Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009.
Jennings CJ; Walsh PM; Deady S; Harvey BJ; Thomas W
Cancer Epidemiol; 2014 Feb; 38(1):35-41. PubMed ID: 24394956
[TBL] [Abstract][Full Text] [Related]
19. Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study.
Cvitanović S; Znaor L; Konsa T; Ivancević Z; Perić I; Erceg M; Vujović M; Vuković J; Beg-Zec Z
Croat Med J; 2003 Oct; 44(5):618-25. PubMed ID: 14515425
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors affecting survival in malignant pleural mesothelioma: analysis of 125 subjects.
Komurcuoglu B; Cirak AK; Kirakli SC; Polat G; Yucel N; Usluer O; Erer O; Balci G; Gayaf M; Guldaval F; Aktogu S; Guclu S; Ozsoz A; Halilcolar H
Tumori; 2014; 100(1):55-9. PubMed ID: 24675492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
